Retrophin competitorsClear all

Retrophin's top competitors include Seelos Therapeutics, Ventria Bioscience, Genoa Pharmaceuticals and GBT (Global Blood Therapeutics).
Retrophin
Retrophin
Retrophin is a biopharmaceutical company which focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases.
Seelos Therapeutics
Seelos Therapeutics
Seelos Therapeutics is a clinical-stage bio-pharmaceutical company.
Ventria Bioscience
Ventria Bioscience
Ventria Bioscience develops life-saving medicines targeting inflammatory, infectious and gastrointestinal diseases.
Genoa Pharmaceuticals
Genoa Pharmaceuticals
Genoa Pharmaceuticals develops therapies for the treatment of idiopathic pulmonary fibrosis.
GBT (Global Blood Therapeutics)
GBT (Global Blood Therapeutics)
GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.
Founding Date
Founding Date
2011
Founding Date
2016
Founding Date
1993
Founding Date
2011
Founding Date
2012
Type
Type
Public
Type
Public
Type
Private
Type
Private
Type
Public
Tags
Locations
Locations
San Diego, US HQ
Dublin, IE
New York, US
Cambridge, US
Locations
HQ
Locations
Junction City, US HQ
Aurora, US
Locations
Seattle, US HQ
Locations
South San Francisco, US HQ
Employees
Employees
21424% increase
Employees
555% decrease
Employees
31
Employees
233% decrease
Employees
17116% increase
Valuation ($)
Valuation ($)
795.6 m
Valuation ($)
50.6 m
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
3.2 b
Twitter followers
Twitter followers
3
Twitter followers
384
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
1.1 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
2
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
53
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
10.5
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
4.8
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
98.11%
Alexa Website Rank
Alexa Website Rank
449035
Alexa Website Rank
743754
Alexa Website Rank
848079
Alexa Website Rank
N/A
Alexa Website Rank
971468

Financial

Net income
Net income
($102.7m) (FY, 2018)
Net income
N/A
Net income
N/A
Net income
N/A
Net income
($174.2m) (FY, 2018)

Funding

Total funding raised
Total funding raised
$ 116m
Total funding raised
N/A
Total funding raised
$ 7.7m
Total funding raised
$ 64.2m
Total funding raised
$ 88.7m
For sources of this data, please see the company profile

View company profiles

Seelos Therapeutics
HQ
Employees
5

Seelos Therapeutics is a clinical-stage bio-pharmaceutical company.

View company
Ventria Bioscience
HQ
Junction City, US
Employees
31

Ventria Bioscience develops life-saving medicines targeting inflammatory, infectious and gastrointestinal diseases.

View company
Genoa Pharmaceuticals
HQ
Seattle, US
Employees
2↓ 33% decrease

Genoa Pharmaceuticals develops therapies for the treatment of idiopathic pulmonary fibrosis.

View company
GBT (Global Blood Therapeutics)
HQ
South San Francisco, US
Employees
171↑ 16% increase

GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.

View company